Recent Posts
See AllThe biosynthetic platform provides a potential simple and efficient method for rapidly producing natural
The Company’s clinical safety team has actively monitored ongoing interim data of patients and found there have been no safety concerns.....
The final terms will be agreed to by the parties after the completion of due diligence by Revive - Expected to close on or before Jan.31.21